Core Viewpoint - Meili Tianyuan Medical Health (02373) announced the repurchase of 30,000 shares on October 30, 2025, for a total transaction amount of approximately HKD 927,150, with an average transaction price of about HKD 30.91 per share [1] Summary by Category - **Share Repurchase Details** - The company repurchased 30,000 shares [1] - The total transaction amount was approximately HKD 927,150 [1] - The average price per share during the transaction was about HKD 30.91 [1]

Core Viewpoint - Meili Tianyuan Healthcare (02373) repurchased 30,000 shares on October 30, 2025, for a total transaction amount of approximately HKD 927,150, with an average price of about HKD 30.91 per share [1] Summary by Category - **Share Repurchase Details** - The company repurchased 30,000 shares [1] - Total transaction amount was approximately HKD 927,150 [1] - Average price per share was about HKD 30.91 [1]

Core Viewpoint - Meili Tianyuan Medical Health (02373) demonstrates strong confidence in its future development through share buybacks and insider purchases, indicating a belief that current share prices do not reflect the company's intrinsic value [1] Group 1: Insider Transactions - Non-executive director Ms. Yi Lin purchased a total of 61,000 shares in the open market using personal funds on October 24, 2025, reflecting a strong belief in the company's future prospects [1] Group 2: Share Buyback Activity - On October 30, 2025, the company repurchased 30,000 shares at a total transaction amount of approximately HKD 927,150, with an average price of about HKD 30.91 per share [1] - From October 15, 2025, to the date of the announcement, the company has repurchased a total of 475,000 shares for a total consideration of approximately HKD 15,069,220 [1] Group 3: Management's Perspective - The board believes that the current trading price of the shares does not reflect their intrinsic value and the actual business prospects of the company [1] - The board asserts that the share buyback reflects management's strong confidence in the long-term value of the enterprise, which is beneficial for enhancing the company's market value and shareholder return capabilities [1]

Core Viewpoint - Meili Tianyuan Medical Health (02373) demonstrates strong confidence in its future development through share buybacks and insider purchases, indicating a belief that current share prices do not reflect the company's intrinsic value [1] Group 1: Insider Transactions - Non-executive director Yi Lin purchased a total of 61,000 shares in the open market on October 24, 2025, using personal funds, reflecting a strong belief in the company's future prospects [1] Group 2: Share Buyback Activity - On October 30, 2025, the company repurchased 30,000 shares at a total cost of approximately 927,150 HKD, with an average price of about 30.91 HKD per share [1] - From October 15, 2025, to the date of the announcement, the company has repurchased a total of 475,000 shares for a total consideration of approximately 15,069,220 HKD [1] Group 3: Management's Perspective - The board believes that the current trading price does not reflect the intrinsic value of the shares and the actual business prospects of the company [1] - The board asserts that the share buyback reflects management's strong confidence in the long-term value of the enterprise and is beneficial for enhancing the company's market value and shareholder return capabilities [1]

表格類別： 股票 狀態： 新提交 公司名稱： 美麗田園醫療健康產業有限公司 呈交日期： 2025年10月31日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02373 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Beauty Farm Medical and Health Industry Inc. 美麗田園醫療健康產業有限公司 * （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：2373） 本公司欣然公佈，本公司於2025年10月30日於市場購回30,000股本公司股份（「股份 * 僅供識別 自願公告 董事增持本公司股份；及 市場股份回購 本公告由美麗田園醫療健康產業有限公司（「本公司」，連同其附屬公司統稱「本集 團」）自願刊發。 董事增持本公司股份 本公司董事（「董事」）會（「董事會」）獲本公司非執行董事易琳女士告知，於2025年10 月24日，彼以自有資金在公開市場購買本公司合共61,000股普通股（「股份」），約佔 於本公告日期本公司已發行股份總數的0.03%，體現出對於本集團未來發展前景的 堅定看好與強烈信心。易琳女士現任德福資本合夥人，擁有逾20年投融資、投資者 關係及 ...

Summary of Key Points Core Viewpoint - Multiple companies conducted share buybacks on October 28, 2025, with China Feihe (06186) leading in both the number of shares repurchased and the total amount spent. Group 1: Buyback Details - China Feihe (06186) repurchased 5.174 million shares for a total of 21.6293 million yuan, representing 0.209% of its total share capital [1][2] - Lianyi Rong Technology (09959) repurchased 1.4625 million shares for 4.7622 million yuan, accounting for 3.638% of its total share capital [2] - Zhongxu Future (09890) repurchased 301,400 shares for 4.4130 million yuan, which is 1.270% of its total share capital [2] Group 2: Other Notable Buybacks - Mengniu Dairy (02319) repurchased 300,000 shares for 4.2977 million yuan, representing 0.563% of its total share capital [2] - Jitu Express (01519) repurchased 385,000 shares for 3.8812 million yuan, which is 0.014% of its total share capital [2] - Kangning Jereh Pharmaceutical (09966) repurchased 320,000 shares for 3.7683 million yuan, accounting for 0.117% of its total share capital [2] Group 3: Additional Companies Involved - Other companies involved in the buyback include: - Guichuang Tongqiao-B (02190) with 50,000 shares repurchased for 1.2065 million yuan [2] - Green City Services (02869) with 208,000 shares repurchased for 969,700 yuan [2] - Tianfu (06868) with 2,000 shares repurchased for 60,400 yuan [3]

Group 1 - The core point of the article is that the non-executive director Yi Lin increased his stake in Meili Tianyuan Medical Health (02373) by purchasing 31,000 shares at a price of HKD 31.82 per share, totaling HKD 986,400 [1] - After the purchase, the total number of shares held by Yi Lin is now 61,000, representing a holding percentage of 0.03% [1]

格隆汇10月28日丨美丽田园医疗健康(02373.HK)公告，10月28日耗资91.7万港元回购3万股。 ...

公司名稱： 美麗田園醫療健康產業有限公司 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 呈交日期： 2025年10月28日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02373 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（ ...